Impact of circulating tumor DNA early detection and serial monitoring in the management of stage I to III colorectal cancer

被引：2

作者：

Roufai, Diana Bello ^{[1
]}

Bidard, Francois-Clement ^{[1
,2
,3
]}

机构：

[1] Inst Curie, Dept Med Oncol, St Cloud, France

[2] Inst Curie, INSERM, Lab Circulating Tumor Biomarkers, Paris, France

[3] Paris Saclay Univ, UVSQ, Paris, France

来源：

ANNALS OF TRANSLATIONAL MEDICINE | 2019年 / 7卷

关键词：

PLASMA; ASSOCIATION; CELLS;

D O I：

10.21037/atm.2019.10.30

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页数：4

共 50 条

[21] Serial monitoring of circulating tumor DNA in patients with metastatic colorectal cancer to predict the therapeutic response.
Zhou, Jianfeng
Jia, Ning
Sun, Zhao
Gao, Xin
Cheng, Yuejuan
Chen, Wei
Shen, Chunying
Bai, Chunmei
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
[22] Circulating tumor DNA as a marker of recurrence risk in stage III colorectal cancer: The α-CORRECT study
Schoen, Robert E.
Diergaarde, Brenda
Young, Gregory
Hall, David W.
Marti, Tara
Mazloom, Amin
Costa, Gina
Subramaniam, Somasundaram
Palomares, Melanie R.
Garces, Jorge
Baehner, Frederick
JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 302 - 302
[23] Circulating tumor DNA monitoring for early recurrence detection in epithelial ovarian cancer
Hou, June Y.
Chapman, Jocelyn S.
Kalashnikova, Ekaterina
Pierson, William
Smith-McCune, Karen
Pineda, Geovanni
Vattakalam, Reena Marie
Ross, Alexandra
Mills, Meredith
Suarez, Carlos J.
Davis, Tracy
Edwards, Robert
Boisen, Michelle
Sawyer, Sarah
Wu, Hsin-Ta
Dashner, Scott
Aushev, Vasily N.
George, Giby, V
Malhotra, Meenakshi
Zimmermann, Bernhard
Sethi, Himanshu
ElNaggar, Adam C.
Aleshin, Alexey
Ford, James M.
GYNECOLOGIC ONCOLOGY, 2022, 167 (02) : 334 - 341
[24] Circulating Tumor DNA as a Marker of Recurrence Risk in Stage III Colorectal Cancer: The α-CORRECT Study
Diergaarde, Brenda
Young, Greg
Hall, David W.
Mazloom, Amin
Costa, Gina L.
Subramaniam, Soma
Palomares, Melanie R.
Garces, Jorge
Baehner, Frederick L.
Schoen, Robert E.
xact Sciences MRD Group
JOURNAL OF SURGICAL ONCOLOGY, 2025,
[25] Serial monitoring of circulating tumor DNA in patients with metastatic breast cancer
Patel, A.
Mukherjee, A.
Hwang, D.
Ensor, J.
Patel, Ta
Chang, J. C.
Rodriguez, A. A.
CANCER RESEARCH, 2017, 77
[26] A multicenter study to evaluate the impact of circulating tumor DNA guided therapy (BESPOKE) in patients with stage II and III colorectal cancer
Kasi, P. M.
Sawyer, S.
Guilford, J.
Munro, M.
Ellers, S.
Hook, N.
Krinshpun, S.
Moshkevich, S.
Billings, P. R.
Aleshin, A.
ANNALS OF ONCOLOGY, 2020, 31 : S459 - S459
[27] Circulating tumor DNA detectable in early- and late-stage colorectal cancer patients
Yang, Ying-Chi
Wang, Dong
Jin, Lan
Yao, Hong-Wei
Zhang, Jing-Hui
Wang, Jin
Zhao, Xiao-Mu
Shen, Chun-Ying
Chen, Wei
Wang, Xue-Liang
Shi, Rong
Chen, Si-Yi
Zhang, Zhong-Tao
BIOSCIENCE REPORTS, 2018, 38
[28] Evaluating personalized circulating tumor DNA detection for early-stage lung cancer
Huang, Haihua
Kai, Zhentian
Wang, Yuchen
Zhang, Xiaomiao
Wang, Jin
Zhang, Wei
Xue, Qian
Zhang, Hang
Jin, Hansong
Meng, Peize
Zhang, Shuilong
Yang, Yueyue
Yang, Honghua
Liang, Wanning
Zha, Guangbing
Luo, Peng
Xu, Yan
Shi, Weiwei
Ruan, Zheng
CANCER MEDICINE, 2024, 13 (10):
[29] DNA methylation profiling from circulating tumor DNA for early-detection of colorectal cancer.
Zhang, Wei
Sui, Jinke
Wu, Xianrui
Cao, Fuao
Yu, Guanyu
Wang, Chenyang
Zhang, Zhihong
Li, Bingsi
Fang, Shuai
Han Han-Zhang
Lou, Zheng
Gong, Haifeng
Liu, Lianjie
Zheng, Nanxin
Hao, Liqiang
Lan, Ping
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
[30] Circulating tumor DNA as an early cancer detection tool
Campos-Carrillo, Andrea
Weitzel, Jeffrey N.
Sahoo, Prativa
Rockne, Russell
Mokhnatkin, Janet V.
Murtaza, Muhammed
Gray, Stacy W.
Goetz, Laura
Goel, Ajay
Schork, Nicholas
Slavin, Thomas P.
PHARMACOLOGY & THERAPEUTICS, 2020, 207

← 1 2 3 4 5 →